Jin Xin, Vanluyten Cedric, Orlitová Michaela, Van Slambrouck Jan, Vos Robin, Verleden Geert M, Godinas Laurent, Neyrinck Arne P, Ingels Catherine, Vanaudenaerde Bart M, De Leyn Paul, Van Veer Hans, Depypere Lieven, Zhang Yi, Van Raemdonck Dirk E M, Ceulemans Laurens J
Department of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium.
Department CHROMETA, Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), KU Leuven, Leuven, Belgium.
J Thorac Dis. 2023 Oct 31;15(10):5811-5822. doi: 10.21037/jtd-23-64. Epub 2023 Oct 25.
Lung re-transplantation (re-LTx) is the only therapeutic option for selected patients with advanced allograft dysfunction. This study aims to describe our center's experience to illustrate the feasibility and safety of off-pump re-LTx avoiding clamshell incision.
We performed a retrospective analysis of 42 patients who underwent bilateral re-LTx between 2007 and 2021. Patients were classified according to their surgical approach and extracorporeal life support (ECLS)-use. Demographics, surgical technique, and short- and long-term outcomes were compared between groups. Continuous data were examined with an independent-sample -test or non-parametric test. Pearson's chi-squared and Fisher's exact were used to analyze categorical data.
Twenty-six patients (61.9%) underwent re-LTx by anterior thoracotomy without ECLS. Compared to the more invasive approach (thoracotomy with ECLS and clamshell with/without ECLS, n=16, 38.1%), clamshell-avoiding off-pump re-LTx patients had a shorter operative time (471.6±111.2 704.0±273.4 min, P=0.010) and less frequent grade 3 primary graft dysfunction (PGD-3) at 72 h (7.7% 37.5%, P=0.038). No significant difference was found in PGD-3 incidence within 72 h, mechanical ventilation, intensive care unit (ICU) and hospital stay, and the incidence of reoperation within 90 days between groups (P>0.05). In the long-term, the clamshell-avoiding and off-pump approach resulted in similar 1- and 5-year patient survival the more invasive approach.
Our experience shows that clamshell-avoiding off-pump re-LTx is feasible and safe in selected patients on a case-by-case evaluation.
肺再次移植(re-LTx)是选定的晚期移植物功能障碍患者的唯一治疗选择。本研究旨在描述我们中心的经验,以说明非体外循环re-LTx避免开胸切口的可行性和安全性。
我们对2007年至2021年间接受双侧re-LTx的42例患者进行了回顾性分析。根据手术方式和体外生命支持(ECLS)的使用情况对患者进行分类。比较各组之间的人口统计学、手术技术以及短期和长期结果。连续数据采用独立样本t检验或非参数检验进行分析。使用Pearson卡方检验和Fisher精确检验分析分类数据。
26例患者(61.9%)通过前外侧开胸术在无ECLS的情况下接受了re-LTx。与更具侵入性的方法(有ECLS的开胸术和有/无ECLS的蚌式切口术,n = 16,38.1%)相比,避免蚌式切口的非体外循环re-LTx患者的手术时间更短(471.6±111.2对704.0±273.4分钟,P = 0.010),72小时时3级原发性移植物功能障碍(PGD-3)的发生率更低(7.7%对37.5%,P = 0.038)。两组之间在72小时内PGD-3发生率、机械通气、重症监护病房(ICU)和住院时间以及90天内再次手术发生率方面未发现显著差异(P>0.05)。从长期来看,避免蚌式切口和非体外循环方法导致的1年和5年患者生存率与更具侵入性的方法相似。
我们的经验表明,在逐例评估的选定患者中,避免蚌式切口的非体外循环re-LTx是可行且安全的。